Atomo Diagnostics Raising $4m to Scale-up Pascal Cassette Supply Amidst Expected Demand Growth

Atomo Diagnostics raising $4m to scale-up Pascal cassette supply amidst expected demand growth

Atomo receives binding commitments from investors for $3m placement priced at 3.3c per share Company seeks to raise up to a further $1m through a share purchase plan Funds will expand commercialisation of proprietary diagnostic tests, scale up supply of Pascal cassettes   Atomo Diagnostics has received binding commitments from institutional and sophisticated professional investors for a placement of shares priced at 3.3c each to raise $3m. The p…

Atomo Diagnostics (ASX:AT1) Raises A$4m as FebriDx CLIA Waiver Unlocks Pascal Volume Upside

Atomo Diagnostics A$4m Raise Funds Scale-Up as FebriDx US Rollout Accelerates Atomo Diagnostics has just completed a fresh capital raise to fund growth. The company raised A$4M through a A$3M placement and a A$1M share purchase plan. The new shares were issued at 3.3 cents each, which represented a 10% discount to the company’s 15-day…

Atomo Diagnostics Completes $4 Million Capital Raise

Atomo Diagnostics Limited (ASX: AT1), an Australian medical device company supplying unique, integrated rapid diagnostic test (RDT) devices to the global diagnostic market, has announced the completion of a capital raise expected to total $4.0 million. The raise was achieved through a placement to institutional and sophisticated professional investors, followed by a Share Purchase Plan (SPP). The company has received binding commitments for $3.0…